CRISPR Therapeutics CRSP Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's total current assets?
- CRISPR Therapeutics (CRSP) reported total current assets of $2.45B in Q1 2026.
- How has CRISPR Therapeutics's total current assets changed year-over-year?
- CRISPR Therapeutics's total current assets increased by 31.1% year-over-year, from $1.87B to $2.45B.
- What is the long-term trend for CRISPR Therapeutics's total current assets?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's total current assets has grown at a 3.0% compound annual growth rate (CAGR), from $1.72B to $1.99B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.